Filtered By:
Specialty: Psychiatry
Drug: Fluoxetine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
Although SSRIs are no longer widely prescribed for post-stroke motor recovery, fluoxetine demonstrated beneficial effects on post-stroke depression (PSD). Given the potential side effects of SSRIs, targeted in...
Source: BMC Psychiatry - November 19, 2022 Category: Psychiatry Authors: Julie Yi, Justin Lu, Annie Yang and Elisabeth Breese Marsh Tags: Research article Source Type: research
Cognitive Impairment After Stroke and Treatment With Fluoxetine: A Planned Analysis of the AFFINITY Randomized Controlled Trial
Am J Geriatr Psychiatry. 2022 Aug 20:S1064-7481(22)00494-8. doi: 10.1016/j.jagp.2022.08.002. Online ahead of print.NO ABSTRACTPMID:36115731 | DOI:10.1016/j.jagp.2022.08.002
Source: The American Journal of Geriatric Psychiatry - September 17, 2022 Category: Psychiatry Authors: Osvaldo P Almeida Graeme J Hankey Andrew Ford Christopher Etherton-Beer Leon Flicker Maree L Hackett AFFINITY Trial Collaboration Source Type: research
Use of antidepressants in unipolar depression in the elderly
CONCLUSIONS: Unipolar major depressive episodes in the elderly are frequent and their medicinal treatment has specific features. Knowing the specificities of antidepressant use in the elderly allows to optimize its efficiency and to limit the risk of inappropriate prescription leading to harmful adverse effects.PMID:35153054 | DOI:10.1016/j.encep.2021.11.006
Source: L Encephale - February 14, 2022 Category: Psychiatry Authors: A Pericaud C Straczek F Montastruc M Leboyer A Yrondi C Arbus Source Type: research
Fluoxetine for Stroke: A Mixed Bag of Outcomes
J Clin Psychiatry. 2021 Jun 8;82(3):21f14106. doi: 10.4088/JCP.21f14106.ABSTRACTStroke is the leading neurologic cause of burden operationalized in terms of disability-adjusted life-years. After stroke, motor deficits, cognitive deficits, and depression cause loss of independence, disability, decreased functioning, and reduced quality of life; these persist into the long term. There are theoretical grounds to consider that, through neuroplasticity and other mechanisms, such impairments can be prevented or attenuated by the early introduction of a selective serotonin reuptake inhibitor such as fluoxetine. However, a recent ...
Source: Journal of Clinical Psychiatry - June 9, 2021 Category: Psychiatry Authors: Chittaranjan Andrade Source Type: research
Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
Translational Psychiatry, Published online: 30 September 2020; doi:10.1038/s41398-020-01008-9Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
Source: Translational Psychiatry - September 29, 2020 Category: Psychiatry Authors: Amin Zahrai Faranak Vahid-Ansari Mireille Daigle Paul R. Albert Source Type: research
Fluoxetine Disappoints in Two New Stroke Trials Fluoxetine Disappoints in Two New Stroke Trials
The antidepressant failed to yield improvements in stroke recovery and was associated with an increase in fracture rates in the EFFECTS and AFFINITY studies.Medscape Medical News
Source: Medscape Psychiatry Headlines - May 14, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation –Liaison Service
AbstractPurpose of ReviewTo provide consultation –liaison psychiatrists with an updated resource that can assist in the treatment and management of geriatric patients.Recent FindingsThe current available literature has not shown any differences in efficacy between haloperidol and second-generation antipsychotics in patients with delirium. When considering relative advantages of forms of antipsychotic administration, there is no support for a superior safety profile of oral compared to intramuscular or intravenous administration. A recent meta-analysis of four randomized controlled trials concluded that when melatonin was...
Source: Current Psychiatry Reports - April 12, 2020 Category: Psychiatry Source Type: research
